Sinovac Biotech Ltd
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -14.9% | +4.2% | +0.0% | +75.0% | +22.3% | +320.4% | +780.9% | -15.7% | -3.2% | -9.7% | -30.0% | |
| – | -17.0% | +4.5% | -2.6% | +117.3% | +23.0% | +346.3% | +855.9% | -18.7% | -2.4% | -10.0% | -33.6% | |
| – | -30.1% | -2.2% | +0.0% | +153.3% | -3.4% | +581.7% | +1,015.2% | -63.1% | -70.3% | -73.6% | +244.9% | |
| – | -30.1% | -2.2% | +0.0% | +183.6% | +14.6% | +479.5% | +1,040.5% | -15.7% | -0.8% | – | – | |
| – | -4.2% | +27.7% | +0.0% | +55.4% | +46.8% | +122.9% | +275.7% | -36.0% | -26.0% | -33.2% | +4.1% | |
| – | -0.3% | -24.4% | +0.0% | +77.9% | +11.0% | +280.0% | +254.9% | -51.9% | -22.6% | -30.7% | -2.7% | |
| – | -6.6% | +4.6% | +14.3% | -7.2% | +14.1% | +251.1% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -54.2% | |
| – | -9.8% | -9.2% | +0.0% | -4.5% | -4.1% | +22.0% | +323.9% | +92.9% | -89.3% | +2,060.8% | -57.8% | |
| – | -31.4% | +23.0% | +0.0% | -4.7% | +28.6% | +680.4% | +267.7% | -51.2% | +16.6% | +25.0% | +9.3% | |
| – | -27.2% | +14.0% | +0.0% | -12.2% | +49.8% | +679.4% | +255.0% | -54.8% | +5.2% | +26.5% | +6.1% | |
| – | -51.5% | +38.5% | +0.0% | -90.1% | +293.8% | +225.9% | -64.6% | -29.4% | +669.4% | – | – | |
| – | -43.5% | +6.9% | +0.0% | +201.5% | +4.6% | +428.2% | +91.8% | -66.2% | -12.8% | -29.2% | +32.5% | |
| – | -58.1% | +1,149.7% | +57.2% | -73.8% | -63.1% | +476.9% | +109.7% | -33.7% | +1,444.5% | -7.9% | +62.0% | |
| – | -3.9% | +6.6% | +0.0% | +95.5% | +16.0% | +153.9% | +1,149.5% | -4.4% | -2.4% | -5.1% | -46.3% | |
| – | – | – | – | – | +138.2% | +154.3% | +4,851.3% | +1.2% | -1.5% | -3.9% | -58.8% | |
| – | +1.1% | +1.1% | +0.0% | +14.1% | +68.8% | +3.6% | +0.3% | +0.1% | -12.8% | -27.9% | +0.0% |
Data as of: September 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.